The organ-on-a-chip developer Emulate has raised $82 million to boost its offerings aimed at replicating human biology through easier-to-manage in vitro cellular models. Used in past drug development ...
AstraZeneca is partnering with Emulate to incorporate organ-on-a-chip technology into the pharma giant’s R&D program. (Emulate photo) () AstraZeneca is partnering with Emulate to incorporate ...
BELLEVUE, Wash.--(BUSINESS WIRE)--EMulate Therapeutics, Inc. (EMulate) announced today the publication of its peer-reviewed clinical trial using EMulate’s technology for the treatment of glioblastoma ...
BELLEVUE, Wash.--(BUSINESS WIRE)--EMulate Therapeutics, Inc. (“EMulate” or the “Company”) is excited to announce that Brett J. Greene will be a new advisor to the Company. He will focus his attention ...
Emulate Inc. has launched a new adeno-associated virus (AAV) transduction application for the Liver-Chip that enables gene therapy researchers to test the delivery efficiency and safety of AAV vectors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results